Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024. https://doi.org/10.3322/caac.21820.

Article  PubMed  Google Scholar 

Kim J, Harper A, McCormack V, et al. Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nat Med. 2025;31(4):1154–62. https://doi.org/10.1038/s41591-025-03502-3.

Article  CAS  PubMed  Google Scholar 

Huang H, Wei T, Zhang A, et al. Trends in the incidence and survival of women with hormone receptor-positive breast cancer from 1990 to 2019: a large population-based analysis. Sci Rep. 2024;14(1):23690. https://doi.org/10.1038/s41598-024-74746-1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lu YS, Im SA, Colleoni M, et al. Updated overall survival of ribociclib plus endocrine therapy versus endocrine therapy alone in pre- and perimenopausal patients with HR+/HER2- advanced breast cancer in MONALEESA-7: a phase III randomized clinical trial. Clin Cancer Res. 2022. https://doi.org/10.1158/1078-0432.CCR-21-3032.

Article  PubMed  PubMed Central  Google Scholar 

Paranjpe R, John G, Trivedi M, et al. Identifying adherence barriers to oral endocrine therapy among breast cancer survivors. Breast Cancer Res Treat. 2019. https://doi.org/10.1007/s10549-018-05073-z.

Article  PubMed  Google Scholar 

Ganna S, Rahimi S, Lu A, et al. Interventions to improve oral endocrine therapy adherence in breast cancer patients. J Cancer Surviv. 2024. https://doi.org/10.1007/s11764-023-01513-y.

Article  PubMed  PubMed Central  Google Scholar 

Eliassen FM, Blåfjelldal V, Helland T, et al. Importance of endocrine treatment adherence and persistence in breast cancer survivorship: a systematic review. BMC Cancer. 2023;23(1):625. https://doi.org/10.1186/s12885-023-11122-8.

Article  PubMed  PubMed Central  Google Scholar 

Chlebowski RT, Kim J, Haque R. Adherence to endocrine therapy in breast cancer adjuvant and prevention settings. Cancer Prev Res. 2014. https://doi.org/10.1158/1940-6207.CAPR-13-0389.

Article  Google Scholar 

Woolpert KM, Schmidt JA, Ahern TP, et al. Clinical factors associated with patterns of endocrine therapy adherence in premenopausal breast cancer patients. Breast Cancer Res. 2024. https://doi.org/10.1186/s13058-024-01819-4.

Article  PubMed  PubMed Central  Google Scholar 

Sood N, Liu Y, Lian M, et al. Association of endocrine therapy initiation timeliness with adherence and continuation in low-income women with breast cancer. JAMA Netw Open. 2022. https://doi.org/10.1001/jamanetworkopen.2022.25345.

Article  PubMed  PubMed Central  Google Scholar 

Weaver KE, Camacho F, Hwang W, et al. Adherence to adjuvant hormonal therapy and its relationship to breast cancer recurrence and survival among low-income women. Am J Clin Oncol. 2013. https://doi.org/10.1097/COC.0b013e3182436ec1.

Article  PubMed  PubMed Central  Google Scholar 

Westhoff CL, Torgal AT, Mayeda ER, et al. Predictors of noncompliance in an oral contraceptive clinical trial. Contraception. 2012. https://doi.org/10.1016/j.contraception.2011.09.019.

Article  PubMed  PubMed Central  Google Scholar 

Murphy CC, Bartholomew LK, Carpentier MY, et al. Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review. Breast Cancer Res Treat. 2012. https://doi.org/10.1007/s10549-012-2114-5.

Article  PubMed  PubMed Central  Google Scholar 

Milata JL, Otte JL, Carpenter JS. Oral endocrine therapy nonadherence, adverse effects, decisional support, and decisional needs in women with breast cancer. Cancer Nurs. 2018. https://doi.org/10.1097/NCC.0000000000000430.

Article  PubMed  PubMed Central  Google Scholar 

Guth U, Myrick ME, Schotzau A, et al. Drug switch because of treatment-related adverse side effects in endocrine adjuvant breast cancer therapy: how often and how often does it work? Breast Cancer Res Treat. 2011. https://doi.org/10.1007/s10549-011-1668-y.

Article  PubMed  Google Scholar 

Yussof I, Mohd Tahir NA, Hatah E, et al. Factors influencing five-year adherence to adjuvant endocrine therapy in breast cancer patients: a systematic review. Breast. 2022. https://doi.org/10.1016/j.breast.2022.01.012.

Article  PubMed  PubMed Central  Google Scholar 

Philipovskiy A, Campbell A, Heydarian R, et al. Adherence to adjuvant aromatase inhibitor therapy among postmenopausal Hispanic/Latino women with breast cancer. Anticancer Res. 2020;40(2):857–64. https://doi.org/10.21873/anticanres.14018.

Article  PubMed  Google Scholar 

Matti N, Delon C, Rybarczyk-Vigouret MC, et al. Adherence to oral anticancer chemotherapies and estimation of the economic burden associated with unused medicines. Int J Clin Pharm. 2020. https://doi.org/10.1007/s11096-020-01083-4.

Article  PubMed  Google Scholar 

Lor M, Koleck TA, Bakken S, et al. Association between health literacy and medication adherence among Hispanics with hypertension. J Racial Ethn Health Disparities. 2019. https://doi.org/10.1007/s40615-019-00588-7.

Article  PubMed  PubMed Central  Google Scholar 

Hilfinger Messias DK, Sharpe PA, Del Castillo-González L, et al. Living in limbo: Latinas’ assessment of Lower Rio Grande Valley colonias communities. Public Health Nurs. 2017;34(3):267–75. https://doi.org/10.1111/phn.12307.

Article  PubMed  Google Scholar 

Biggers A, Shi Y, Charlson J, et al. Medicare D subsidies and racial disparities in persistence and adherence with hormonal therapy. J Clin Oncol. 2016. https://doi.org/10.1200/JCO.2016.67.3350.

Article  PubMed  PubMed Central  Google Scholar 

Hershman DL, Tsui J, Wright JD, et al. Household net worth, racial disparities, and hormonal therapy adherence among women with early-stage breast cancer. J Clin Oncol. 2015. https://doi.org/10.1200/JCO.2014.58.3062.

Article  PubMed  PubMed Central  Google Scholar 

Faul F, Erdfelder E, Lang AG, et al. G*power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007. https://doi.org/10.3758/BF03193146.

Article  PubMed  Google Scholar 

Hershman DL, Shao T, Kushi LH, et al. Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat. 2011. https://doi.org/10.1007/s10549-010-1132-4.

Article  PubMed  PubMed Central  Google Scholar 

Bhandari S, Ngo P, Kute B, et al. Adherence to anti-estrogen therapy in women with hormone receptor-positive breast cancer utilizing bubble packaging: a pilot study. Breast Cancer Res Treat. 2019. https://doi.org/10.1007/s10549-019-05308-7.

Article  PubMed  Google Scholar 

Hershman DL, Kushi LH, Shao T, et al. Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol. 2010. https://doi.org/10.1200/JCO.2009.25.9655.

Article  PubMed  PubMed Central  Google Scholar 

Spencer JC, Reeve BB, Troester MA, et al. Factors associated with endocrine therapy non-adherence in breast cancer survivors. Psychooncology. 2020. https://doi.org/10.1002/pon.5289.

Article  PubMed  PubMed Central  Google Scholar 

Bekele BB, Lian M, Schmaltz C, et al. Preexisting diabetes and breast cancer treatment among low-income women. JAMA Netw Open. 2024. https://doi.org/10.1001/jamanetworkopen.2024.9548.

Article  PubMed  PubMed Central  Google Scholar 

Hwang GS, Paranjpe R, Opsomer C, et al. Oral endocrine therapy agent, race/ethnicity, and time on therapy predict adherence in breast cancer patients in a large academic institution. Clin Breast Cancer. 2020. https://doi.org/10.1016/j.clbc.2020.06.004.

Article  PubMed